Active — Not RecruitingPhase 1

Vertical Ridge Augmentation Using Computer-guided Sandwich Osteotomy Technique

Egypt12 participantsStarted 2024-05-09

Plain-language summary

Researcher will introduce the trial to patients and provide full explanation of its aim and benefits in Arabic language. Patients will then be able to have an informed discussion with the researcher. Researcher will obtain written consent from patients willing to participate in the trial

Who can participate

Age range30 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * Adults (age 30-45) with vertical ridge deficiency. * Patients with maxillary vertical ridge deficiency 4-8mm according to Cologne Classification of Alveolar Ridge Defects (CCARD). * Patients with good oral hygiene. * Free from systemic diseases that may influence the outcome of the therapy. Exclusion criteria * Systemic conditions which are generally considered to be a contraindication to implant surgery which included but not limited to: osteoporosis, uncontrolled diabetes. * Pregnant or lactating females * Current or former smokers. * Patient treated by immunosuppressive chemotherapy or radio therapy, * Allergy to any material or medication used in the study.

What they're measuring

Effect of RGD on volumetric bone changes

Timeframe: Preoperative Cone beam computed tomography (CBCT) with minimal field of view will be taken for (implant treatment plan), immediately after surgery, at time of loading and 6 months after loading.

Trial details

NCT IDNCT07028606

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-10

View on ClinicalTrials.gov More Alveolar Bone Resorption trials